A wander in the beeches is a religious experience
The nature reserve of Burnham Beeches, a couple of miles above Slough's trading estate, is justly famed for its numerous and titular Fagus sylvatica. George Orwell was an admirer; in Keep the Aspidistra Flying, 1936, Gordon and Rosemary, on a day out from their drearisome London life, fall into extravagant happiness seeking a suitable epithet for the beech trees there: 'Both agreed that beeches look more like sentient creatures than other trees. It is because of the smoothness of their bark, probably, and the curious limb-like way in which the boughs sprout from the trunk.'
The historic pollarding — pruning at head height — of Burnham's beeches has produced admittedly animalesque trees, but sometimes of writhing agony. Burnham's beeches haunt the mind. They possess soul too, since to enter a summer beech wood is to step into a cathedral: the extraordinary estival density of the foliage produces a mystried gloom.
The other way around, of course, since to enter a cathedral is to enter a beech grove; the Gothic architects of our great houses of prayer were inspired by the beech, with its numinousness and elegant ability to buttress the roof of the heavens.
• Rain at last but age-old patterns are moving fast
There are other wonders at Burnham, such as wood ants, of which the reserve has 500 colonies. Each domed metre-high nest possesses 250,000-plus inhabitants. If ants have a reputation for industry, their cleverness is insufficiently praised. Wood ants lay the grass-and-twig thatch roof on the formicarium in such a way that it acts as a solar panel. Temperature inside the domed abode is regulated by ants opening and closing tiny holes in the roof. Humans call this sun-utilisation 'sustainable eco-living'.
There are six species of British wood ant, but only three are commonly encountered: the northern hairy, Scottish and southern. Burnham's ants are the latter sort, Formica rufa. Reddish, but with a jet-black abdomen. Workers reach 10mm in length, queens a stately 12mm. Their 'flying season' begins in late June, when winged males and queens emerge en masse and take to the air to mate and form yet more colonies.
• How a plague of 'mirror bacteria' could destroy all life on Earth
Common broomrape is a parasitic perennial, entirely lacking chlorophyll; on first poking through the ground it takes an unseemly mauve hue but soon turns brown, at which point it looks akin to an intricately carved stick. Orobanche minor rarely appears in the singular, coming in platoons.
The veronica bush in our garden is hosting 80-plus broomrapes packed under its shade, with one specimen measuring 61cm. In the bush's twilight zone, the broomrapes present an unearthly spectacle: they have no proper dirt-seeking roots so they suck nutrients out of the veronica's uppermost roots via their 'haustoria', special penetrating tubes.
When not invading gardens, common broomrape succours on clovers, although there are numerous sub-species, including maritima. This latter is vampiric on sea carrots. And the reason for the unattractive name of this unattractive plant? Gerard's Herbal of 1597 notes the plant, or another close member of the Orobanchaceae, growing 'unto the roots of broome', the gold-flowered shrub. The old country names of 'devil-root' and 'hell-root' for Orobanche minor indicates that its infestation of clover in the meadow is historically trying for farmers.
Last week in the Charente, France, my 4km cycle rides to town to 'faire le shopping' were traffic-free, except for pine martens. On one occasion a pair ran along the other side of the road, keeping perfect lane discipline, but mostly the cat-sized mammal ran across the tarmac in front of the bike's wheels. This was in broad daylight.
A member of the weasel family, Martes martes is weaselly recognisable: in addition to the sort of glossy chestnut hair one associates with shampoo adverts, it possesses a stand-out creamy-orange bib. The exact shape and extent of the bib is particular to each individual. In Britain, the pine marten is rare and restricted to the forests of Scotland, northern England, north Wales and small, partly reintroduced populations in southwest England.
The mustelid's French cousin is seemingly carefree about the 'pine' designation, or indeed a definite affinity with woodland. The stretch of 'La France Profonde' for my shopping trips consisted of sunflowers and wheat fields. A sole line of shimmering poplar trees along the brook seems sufficient treeness to satisfy the marten's need to climb and nest above ground, thus beyond the jaws of a predator even bigger and badder than itself: Monsieur Renard.
John Lewis-Stempel's latest book is The Curious Life of the Cuckoo
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
an hour ago
- Daily Mail
Erectile dysfunction drug Viagra has surprise new health benefit, scientists find - offering new hope to 3million ageing Britons
A surprising new health benefit has emerged from the sex drug Viagra - which means three million ageing Britons can now also enjoy a harder skull. The little blue tablet was found to increase the production of vital bone cells, preventing back pain and fractures in old age. Sildenafil - also known as Viagra - can help human stem cells transform into osteoblasts which help the human skeleton regenerate as it is completely replaced roughly once every 10 years. As humans get older, they lose more bone than is built, increasing the risk of breaks or osteoporosis, which makes bones brittle and painful. Follow-up tests on mice by Peking University also suggested a prevention of bone loss. Dr Menglong Hu and Dr Likun Wu told MailOnline: 'Our findings offer new insights into the physiological effects of the medicine. 'Sildenafil enhanced stem cell osteogenic differentiation and inhibited bone loss — it may usefully treat osteoporosis.' Viagra was invented as a heart drug in the 1980s before being found to help with erectile dysfunction. Some studies suggest it may also help reduce the risk of dementia. However, the have been cautions over the years that the drug could have some negative side effects, in particular if taken too much. A large quantity of the drug could result in a painful, 'uncomfortably and disproportionately large erection' called a priapism which could go on for hours. Some experts also found regularly taking the common drug may raise the risk of three serious eye conditions. Common side effects may include headaches, hot flushes, nausea, indigestion, dizziness and a stuffy nose. Nearly half of men between the ages of 40 and 70 suffer from erectile dysfunction in the UK - this is more than 4.5 million people. Though, reports suggest Viagra is now even becoming increasingly popular with younger individuals in their 20s and 30s. Last year, it emerged Viagra may help prevent dementia by boosting blood flow in the brain. 'This is the first trial to show that sildenafil gets into the blood vessels in the brain in people with this condition, improving blood flow and how responsive these blood vessels are,'Dr Alastair Webb, a neurologist and study author at Oxford University said.
The Independent
3 hours ago
- The Independent
Nearly 600 heat-related deaths expected in UK heatwave, researchers estimate
Nearly 600 people in England and Wales are predicted to die as a result of this week's heatwave, researchers have found. Experts at the London School of Hygiene and Tropical Medicine (LSHTM) and Imperial College London used decades of UK data to predict excess mortality during the hot temperatures from Thursday to Sunday. Their study, released on Saturday, forecasts that around 570 people will die because of the heat over the four days. The excess deaths are estimated to peak at 266 on Saturday when the heat will be at its most intense. London is predicted to have the greatest number of excess deaths with 129. The researchers said their assessment highlights how extreme heat poses a growing threat to public health in the UK. It follows a World Weather Attribution (WWA) research group study published on Friday which found the heatwave has been made about 100 times more likely and 2-4C hotter due to climate change. Dr Garyfallos Konstantinoudis, lecturer at the Grantham Institute at Imperial College London, said: 'Heatwaves are silent killers – people who lose their lives in them typically have pre-existing health conditions and rarely have heat listed as a contributing cause of death. 'This real-time analysis reveals the hidden toll of heatwaves and we want it to help raise the alarm. 'Heatwaves are an underappreciated threat in the UK and they're becoming more dangerous with climate change.' Dr Konstantinoudis warned that people should follow heat-health advice this weekend and check on older people, particularly those living alone. Temperatures had been forecast to hit 32C across the South East on Saturday and had already reached that level on Thursday in London. The UK Health Security Agency issued an amber heat-health alert covering all of England to warn vulnerable populations of the health risks, including 'a rise in deaths'. Dozens of people required treatment for heat-related illness at Royal Ascot on Thursday. The researchers used findings from published research on the relationship between heat and the number of daily deaths, regardless of the cause, in 34,753 areas of England and Wales. They combined these with high-resolution weather forecasts from the Copernicus climate change service to estimate how many heat-related deaths will occur. They estimated that 114 excess deaths would have occurred on Thursday, 152 on Friday, 266 on Saturday and 37 deaths on Sunday, when temperatures will fall to the mid-20s. People above 65 are expected to be hardest hit, with 488 of the estimated excess deaths, the report said. But the experts also warn that heat can be life-threatening for all ages, with 82 deaths estimated for people aged under 65. They also note that the analysis does not account for the effect of the heatwave occurring early in summer before people are acclimatised to hot temperatures, meaning deaths could be underestimated. A recent report by the UK Climate Change Committee estimated that heat-related deaths could rise to more than 10,000 in an average year by 2050 if fossil fuel burning causes warming to reach 2C. UN scientists warned this week that the world is in 'crunch time' to limit warming and has three years left to prevent global average temperature rises exceeding 1.5C. Professor Antonio Gasparrini, of the LSHTM, said: 'Increases of just a degree or two can be the difference between life and death. 'Every fraction of a degree of warming will cause more hospital admissions and heat deaths, putting more strain on the NHS.' Dr Malcolm Mistry, assistant professor at the LSHTM, said: 'Exposure to temperatures in the high 20s or low 30s may not seem dangerous, but they can be fatal, particularly for people aged over 65, infants, pregnant people and those with pre-existing health conditions. 'Unless effective mitigation and adaptive measures are put in place in the coming years, the risk of large heat-related death events is set to increase in the UK – we have a large ageing population and warming is expected to increase to 2C by 2050 and as high as 3C this century.' Dr Lorna Powell, an NHS urgent care doctor in east London who was not involved in the study, said: 'We are seeing cases of heat-related illnesses rising in our urgent care departments. 'Heat exhaustion can quickly trigger more serious illnesses as dehydration sets in and the cardiovascular system becomes overwhelmed.'
The Independent
3 hours ago
- The Independent
Weight loss jab could be used to treat migraines
Weight loss jabs could cut the number of migraines sufferers experience by half, research suggests. The drugs, similar to Ozempic and Wegovy, also known as GLP-1 receptor agonists, work by mimicking the natural hormone which regulates blood sugar, appetite and digestion. Researchers have discovered, GLP-1 drug liraglutide, commonly used to treat diabetes, has the potential to significantly reduce migraine frequency. Migraines affect approximately 6 million people in the UK, according to the NHS. Attacks can last for three days causing pain, nausea, vomiting, dizziness and sensitivity to light, sound and smells. Researchers at the Headache Centre of the University of Naples gave 26 adults with obesity and chronic migraines the drug liraglutide. The study presented at the European Academy of Neurology (EAN) Congress 2025, found those who had the drug reported an average of 11 fewer headache days per month. Participants also experienced meaningful improvements in quality of life, work, study, and social functioning within just two weeks of taking the drug. 'Most patients felt better within the first two weeks and reported quality of life improved significantly', said lead researcher Dr Simone Braca. 'The benefit lasted for the full three-month observation period, even though weight loss was modest and statistically non-significant.' Growing evidence has linked subtle increases in intracranial pressure to migraine attacks. It's caused by a rise in the pressure of cerebrospinal fluid – which surrounds the brain and spinal cord. This increase in pressure can happen because of a severe head injury, stroke, a brain tumour or high blood pressure. But GLP-1-receptor agonists such as liraglutide reduce cerebrospinal fluid secretion and have already proved effective in treating idiopathic intracranial hypertension (IIH). Patients in the study were screened to exclude papilledema (optic disc swelling resulting from increased intracranial pressure) and sixth nerve palsy, ruling out IIH. Dr Braca and colleagues believe GLP-1 drugs may reduce the release of CGRP (calcitonin gene-related peptide), a key molecule behind migraines. 'We think that, by modulating cerebrospinal fluid pressure and reducing intracranial venous sinuses compression, these drugs produce a decrease in the release of calcitonin gene-related peptide (CGRP), a key migraine-promoting peptide', Dr Braca said. 'That would pose intracranial pressure control as a brand-new, pharmacologically targetable pathway.' Given liraglutide's established use in type 2 diabetes and obesity, it may represent a promising case of drug repurposing in neurology, study authors said.
